Kristina B. Emdal
-
- Bioinformatics and Genomic Networks 2
- Protein Degradation and Inhibitors 2
-
- Cancer, Hypoxia, and Metabolism 3
- Spectroscopy top 10%
- Advanced Proteomics Techniques and Applications 2
-
- Cytokine Signaling Pathways and Interactions 2
- Colorectal Cancer Treatments and Studies 2
-
- Neuroblastoma Research and Treatments 2
-
- Estrogen and related hormone effects 2
- Co-authors
- Jesper V. OlsenDorte B. Bekker‐JensenChiara FrancavillaAnne E. LykkesfeldtBárbara GuerraChristina W. YdeGianni CarraroForest M. White
- Partner nations
- DenmarkUnited KingdomUnited States
In The Last Decade
Kristina B. Emdal
15 papers receiving 605 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 469
- Cancer Research 99
- Spectroscopy 85
- Oncology 127
- Cell Biology 65
Countries citing papers authored by Kristina B. Emdal
This map shows the geographic impact of Kristina B. Emdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina B. Emdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina B. Emdal more than expected).
Fields of papers citing papers by Kristina B. Emdal
This network shows the impact of papers produced by Kristina B. Emdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina B. Emdal. The network helps show where Kristina B. Emdal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kristina B. Emdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 19 | |
| 3 | 2022 | 21 | |
| 4 | 2021 | 90 | |
| 5 | 2019 | 62 | |
| 6 | 2019 | 49 | |
| 7 | 2018 | 32 | |
| 8 | 2017 | 23 | |
| 9 | 2017 | 49 | |
| 10 | Characterization of in vivo resistance to osimertinib and JNJ-61186372, an EGFR/Met bi-specific antibody, reveals unique and consensus mechanisms of resistance | 2017 | 1 |
| 11 | 2016 | 16 | |
| 12 | 2015 | 56 | |
| 13 | 2013 | 111 | |
| 14 | 2012 | 48 | |
| 15 | 2009 | 27 |
About Kristina B. Emdal
Kristina B. Emdal is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 15 papers that have together received 606 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Neuroblastoma Research and Treatments (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Bioinformatics and Genomic Networks (2 papers), Protein Degradation and Inhibitors (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Molecular Biology (469 citations), Cancer Research (99 citations) and Spectroscopy (85 citations). Kristina B. Emdal has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Jesper V. Olsen, Dorte B. Bekker‐Jensen, Chiara Francavilla, Anne E. Lykkesfeldt, Bárbara Guerra, Christina W. Yde, Gianni Carraro, Forest M. White, Lars Juhl Jensen and Mats Wikström. Their work appears in journals such as Nature, Cell and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.